Chat about Advanced Oncotherapy accounts information. See how Advanced Oncotherapy is performing financially.

Advanced Oncotherapy Accounts Summary


Date of Accounts 20212020201920182017
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-202131-12-202031-12-201931-12-201831-12-2017
Revenuen/an/an/an/an/a
Operating Profit / Loss-23.74-20.27-20.66-21.85-14.49
Net Interest-5.76-5.03-1.22-0.07-1.99
Pre Tax Profit-29.49-25.30-21.88-21.91-16.49
Post Tax Profit-29.49-25.30-20.79-21.15-13.66
Profit for the Period-29.49-25.30-20.79-21.15-13.66
Equity Holders of Parent Company-29.49-25.30-20.79-21.15-13.66
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-7.71p-8.75p-9.83p-14.05p-17.55p
Earnings per Share (Diluted)-7.71p-8.75p-9.83p-14.05p-17.55p
Earnings per Share (Adjusted)-7.71p-8.75p-9.83p-14.05p-17.55p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-7.71p-8.75p-9.83p-14.05p-17.55p
Earnings per Share (Diluted)-7.71p-8.75p-9.83p-14.05p-17.55p
Earnings per Share (Adjusted)-7.71p-8.75p-9.83p-14.05p-17.55p
      
Dividend per Sharen/apn/apn/apn/apn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-202131-12-202031-12-201931-12-201831-12-2017
Non-Current Assets     
Intangible Assets68.5856.8749.1840.1730.57
Property, Plant and Equipment41.0638.1538.534.091.18
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/a0.310.31
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assets0.930.930.911.210.84
Total Non-Current Assets110.5695.9588.6345.7732.90
      
Current Assets     
Inventories25.8322.1415.0510.017.63
Trade and Other Receivables0.641.892.141.961.96
Cash at Bank and in Hand4.262.323.241.010.06
Current Asset Investmentsn/an/an/an/an/a
Other Current Assetsn/an/a1.770.692.85
Total Current Assets30.7326.3422.1913.6812.50
      
Other Assetsn/an/an/an/an/a
Total Assets141.29122.29110.8259.4545.40
      
Current Liabilities     
Borrowings10.7712.771.593.009.25
Other Current Liabilities5.356.444.885.957.49
Total Current Liabilities16.1219.216.488.9516.74
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings42.5837.8644.91n/an/a
Provisionsn/an/an/an/an/a
Other Non-Current Liabilities21.2221.0816.5016.50n/a
Total Non-Current Liabilities63.8058.9461.4116.50n/a
      
Net Assets61.3744.1442.9434.0029.00
      
Capital and Reserves     
Share Capital112.9083.3661.1142.3920.00
Share Premium Account71.0961.4460.4550.7243.00
Other Reserves28.8821.6119.8819.6923.00
Retained Earnings-151.50-122.27-98.50-78.81-58.00
Shareholders Funds61.3744.1442.9434.0029.00
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity61.3744.1442.9434.0029.00
      
 31-12-202131-12-202031-12-201931-12-201831-12-2017
Operating Marginn/a%n/a%n/a%n/a%n/a%
Return on Capital Employed-51.44%-53.47%-51.32%689.05%-188.80%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/an/an/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share-1.46p-2.57p-1.26p-1.25p-0.32p